Acute Myeloid Leukemia with NPM1 Mutation and Disseminated Leukemia Cutis: Achievement of Molecular Complete Remission by Venetoclax/Azacitidine Combination in a Very Old Patient

被引：6
|
作者：
Niscola, Pasquale [1 ,5 ]
Mazzone, Carla [1 ]
Fratoni, Stefano [2 ]
Ardu, Nicolina Rita [1 ]
Cesini, Laura [1 ]
Giovannini, Marco [1 ]
Ottone, Tiziana [4 ]
Anemona, Lucia [3 ]
Voso, Maria Teresa [4 ]
de Fabritiis, Paolo [1 ]
机构：
[1] ASL Roma 2, S Eugenio Hosp, Hematol Unit, Rome, Italy
[2] ASL Roma 2, S Eugenio Hosp, Pathol Dept, Rome, Italy
[3] Univ Roma Tor Vergata, Dept Biomed & Prevent, Anat Pathol, Rome, Italy
[4] Univ Roma Tor Vergata, Dept Biomed & Prevent, Rome, Italy
[5] S Eugenio Hosp, Hematol Unit, Piazzale Umanesimo 10, I-00144 Rome, Italy
来源：
ACTA HAEMATOLOGICA | 2023年 / 146卷 / 05期
关键词：
Acute myeloid leukemia; Leukemia cutis; Nucleophosmin-1; Venetoclax; azacitidine; VENETOCLAX;
D O I：
10.1159/000531101
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
We describe a case of acute myeloid leukemia with NPM1 mutation and disseminated leukemia cutis in a very old patient, who achieved a long-lasting response to the azacitidine/venetoclax combination with molecular complete remission, given the potential value of this rarely observed clinical outcome.
引用
收藏
页码：408 / 412
页数：5
相关论文
共 50 条
  • [31] Comprehensive Age-Stratified Impact of NPM1 Mutation in Acute Myeloid Leukemia: A Real-World Experience
    Dhillon, Vikram
    Khan, Abdul Moiz
    Aguilar, Jeff Justin M.
    Reddy, Sushmitha Nanja
    Aly, Mai M.
    Kewan, Tariq
    Bahaj, Waled
    Gurnari, Carmelo
    Visconte, Valeria
    Carr, David
    Boerner, Julie
    Yang, Jay
    Dyson, Gregory
    Maciejewski, Jaroslaw
    Balasubramanian, Suresh Kumar
    CANCERS, 2025, 17 (06)
  • [32] Mutated NPM1 in combination with overexpression of Meis1 or Hoxa9 is not sufficient to induce acute myeloid leukemia
    Wiktorin H.G.
    Nilsson T.
    Jansson A.
    Palmqvist L.
    Martner A.
    Experimental Hematology & Oncology, 5 (1)
  • [33] Erdheim-Chester Disease and Acute Myeloid Leukemia with Mutated NPM1 in a Patient with Clonal Hematopoiesis: A Case Report
    Papageorgiou, Sotirios G.
    Divane, Aspasia
    Roumelioti, Maria
    Kottaridi, Christine
    Bouchla, Anthi
    Georgakopoulos, Alexandros
    Ieremiadou, Fotini
    Daraki, Aggeliki
    Bazani, Efthymia
    Thomopoulos, Thomas P.
    Chatziioannou, Sofia
    Mavrogenis, Andreas
    Panayiotidis, Panayiotis
    Panayiotides, Ioannis G.
    Pappa, Vasiliki
    Foukas, Periklis G.
    ONCOTARGETS AND THERAPY, 2020, 13 : 11689 - 11695
  • [34] Reversal of FLT3 Mutational Status and Sustained Expression of NPM1 Mutation in Paired Presentation, and Relapse Samples in a Patient with Acute Myeloid Leukemia
    Radojkovic, Milica
    Tosic, Natasa
    Colovic, Natasa
    Ristic, Slobodan
    Pavlovic, Sonja
    Colovic, Milica
    ANNALS OF CLINICAL AND LABORATORY SCIENCE, 2012, 42 (02) : 186 - 190
  • [35] A one-mutation mathematical model can explain the age incidence of acute myeloid leukemia with mutated nucleophosmin (NPM1)
    Liso, Arcangelo
    Castiglione, Filippo
    Cappuccio, Antonio
    Stracci, Fabrizio
    Schlenk, Richard F.
    Amadori, Sergio
    Thiede, Christian
    Schnittger, Susanne
    Valk, Peter J. M.
    Doehner, Konstanze
    Martelli, Massimo F.
    Schaich, Markus
    Krauter, Juergen
    Ganser, Arnold
    Martelli, Maria P.
    Bolli, Niccolo
    Loewenberg, Bob
    Haferlach, Torsten
    Ehninger, Gerhard
    Mandelli, Franco
    Doehner, Hartmut
    Michor, Franziska
    Falini, Brunangelo
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 (08): : 1219 - 1226
  • [36] Mutation of the NPM1 gene contributes to the development of donor cell-derived acute myeloid leukemia after unrelated cord blood transplantation for acute lymphoblastic leukemia
    Rodriguez-Macias, Gabriela
    Martinez-Laperche, Carolina
    Gayoso, Jorge
    Noriega, Victor
    Serrano, David
    Balsalobre, Pascual
    Munoz-Martinez, Cristina
    Diez-Martin, Jose L.
    Buno, Ismael
    HUMAN PATHOLOGY, 2013, 44 (08) : 1696 - 1699
  • [37] Immunohistochemical Detection of NPM1 Mutation in Acute Myeloid Leukemia and its Association With Cup-like Nuclear Morphology of Blasts
    Rastogi, Pulkit
    Naseem, Shano
    Varma, Neelam
    Varma, Subhash
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2016, 24 (04) : 261 - 267
  • [38] Prognostic impact of early minimal residual disease combined with complete molecular evaluation in acute myeloid leukemia with mutated NPM1: a single center study
    Memoli, Mara
    Genthon, Alexis
    Favale, Fabrizia
    Lapusan, Simona
    Johnson, Natacha
    Adaeva, Rosa
    Deswarte, Caroline
    Battipaglia, Giorgia
    Malard, Florent
    Dulery, Remy
    Brissot, Eolia
    Banet, Anne
    Van de Wyngaert, Zoe
    Mohty, Mohamad
    Delhommeau, Francois
    Legrand, Ollivier
    Hirsch, Pierre
    LEUKEMIA & LYMPHOMA, 2022, 63 (09) : 2171 - 2179
  • [39] Epigenetic down-regulation of the HIST1 locus predicts better prognosis in acute myeloid leukemia with NPM1 mutation
    Garciaz, Sylvain
    Dasi, Lia N'guyen
    Finetti, Pascal
    Chevalier, Christine
    Vernerey, Julien
    Poplineau, Mathilde
    Platet, Nadine
    Audebert, Stephane
    Pophillat, Matthieu
    Camoin, Luc
    Bertucci, Francois
    Calmels, Boris
    Recher, Christian
    Birnbaum, Daniel
    Chabannon, Christian
    Vey, Norbert
    Duprez, Estelle
    CLINICAL EPIGENETICS, 2019, 11 (01)
  • [40] Epigenetic down-regulation of the HIST1 locus predicts better prognosis in acute myeloid leukemia with NPM1 mutation
    Sylvain Garciaz
    Lia N’guyen Dasi
    Pascal Finetti
    Christine Chevalier
    Julien Vernerey
    Mathilde Poplineau
    Nadine Platet
    Stéphane Audebert
    Matthieu Pophillat
    Luc Camoin
    François Bertucci
    Boris Calmels
    Christian Récher
    Daniel Birnbaum
    Christian Chabannon
    Norbert Vey
    Estelle Duprez
    Clinical Epigenetics, 2019, 11
12345